Unicef launched a USD 5 million programme in India for providing zinc supplementation and oral rehydration therapy to contain diarrhoea in children, officials associated with the project said ...

Unicef Canada and Teck, a mineral company, launched the new program that will save over 150,000 children's lives in India. Vaccination for Children Vaccines are biological products that impart ...

It is an adequate glucose-electrolyte solution called the Oral Rehydration Salts (ORS) solution. It was first used in 1969, and then a new solution has been recommended by the WHO and the UNICEF ...

WHO and UNICEF recommends ORS solution containing 75 mEq/l of sodium with a low osmolarity of 245 mOsm/l. ... In India, doctors had already realised the futility of IV drips to treat diarrhea.

WHO provides the only updated international quality specifications for this formula and UNICEF is a leading supplier of ORS to poor countries. ... India To Become 4th Largest Economy Soon!

The World Health Organization (WHO) and UNICEF have announced a new formula for the preparation of Oral Rehydration Salts (ORS) that is designed to minimize the occurrence of acute diarrhoeal disease.

Researchers studied ORS prescription among 2,282 providers in two areas in India: Karnataka, which has above-average per capita income and above-average use of oral rehydration salts; and Bihar ...

The World Health Organisation (WHO) and Unicef recommend an ORS formulation with a total osmolarity of 245 mOsm/L. This formula includes specific amounts of sodium chloride (2.6 grams/litre ...

According to the study, there are several popular explanations for the underprescription of ORS in India, which accounts for the most cases of child diarrhea of any country in the world ...

Makers of ORSL Launch Ready-to-Drink W.H.O. ORS, available in Apple and Orange Flavours. Backed by science and recommended by experts, ORSL ®, India's No.1 Ready-to-Drink electrolyte drink brand ...

The study was conducted across 253 medium sized towns (population between 10,000 and 1.5 lakh) in Karnataka and Bihar to explore the reasons for underprescription of ORS in India.